Predicting outcomes in hyperthyroid cats treated with radioiodine

被引:6
|
作者
Peterson, Mark E. [1 ,2 ]
Rishniw, Mark [2 ,3 ]
机构
[1] Anim Endocrine Clin, 220 Manhattan Ave, New York, NY 10025 USA
[2] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA
[3] Vet Informat Network, Davis, CA USA
关键词
I-131; feline; hypothyroidism; radioactive iodine; thyroid gland; treatment failure; THYROID-STIMULATING HORMONE; TOXIC NODULAR GOITER; RADIOACTIVE IODINE; LOGISTIC-REGRESSION; FELINE HYPERTHYROIDISM; PROGNOSTIC-FACTORS; THERAPY; HYPOTHYROIDISM; PERTECHNETATE; I-131;
D O I
10.1111/jvim.16319
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background Radioiodine (I-131) is the treatment of choice for cats with hyperthyroidism. After I-131, however, euthyroidism is not always achieved, with 5% to 10% of cats remaining persistently hyperthyroid and 20% to 50% developing iatrogenic hypothyroidism. Objectives To identify pretreatment factors that may help predict persistent hyperthyroidism and iatrogenic hypothyroidism after treatment of cats using a novel I-131 dosing algorithm. Animals One thousand and four hundred hyperthyroid cats treated with I-131. Methods Prospective, before-and-after study. Pretreatment predictors (clinical, laboratory, scintigraphic, I-131 dose, I-131 uptake measurements) of treatment failure or iatrogenic hypothyroidism were identified by multivariable logistic regression analysis. Results Cats that developed iatrogenic hypothyroidism were more likely to be older (odds ratio [OR] = 1.10; 95% confidence interval [CI], 1.04-1.17; P = .001), female (OR = 2.04; 95% CI, 1.54-2.70; P < .001), have detectable serum thyroid-stimulating hormone (TSH) concentrations (OR = 4.19; 95% CI, 2.0-8.81; P < .001), have bilateral thyroid nodules (OR = 1.57; 95% CI, 1.19-2.08; P < .001), have homogeneous, bilateral distribution of Tc-99m-pertechnetate uptake (OR = 2.93; 95% CI, 2.05-4.19; P < .001), have milder severity score (OR = 0.62; 95% CI, 0.49-0.79; P < .001), and have higher I-131 uptake (OR = 2.40; 95% CI, 1.75-3.28; P < .001). In contrast, cats remaining persistently hyperthyroid were more likely to be younger (OR = 0.81; 95% CI, 0.72-0.92; P < .001), have higher severity score (OR = 1.87; 95% CI, 1.51-2.31; P < .001), and have lower I-131 uptake (OR = 3.50; 95% CI, 1.8-6.80; P < .001). Conclusions and Clinical Importance Age, sex, serum TSH concentration, bilateral and homogeneous Tc-99m-pertechnetate uptake on scintigraphy, severity score, and percent I-131 uptake are all factors that might help predict outcome of I-131 treatment in hyperthyroid cats. Cats with persistent hyperthyroidism had many predictive factors that directly contrasted those of cats that developed I-131-induced hypothyroidism.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 50 条
  • [21] Prevalence and degree of thyroid pathology in hyperthyroid cats increases with disease duration: a cross-sectional analysis of 2096 cats referred for radioiodine therapy
    Peterson, Mark E.
    Broome, Michael R.
    Rishniw, Mark
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2016, 18 (02) : 92 - 103
  • [22] Abdominal Ultrasound Examination Findings in 534 Hyperthyroid Cats Referred for Radioiodine Treatment Between 2007-2010
    Nussbaum, L. K.
    Scavelli, T. D.
    Scavelli, D. M.
    Pintar, J.
    Henderson, A. K.
    DeMarco, J. A.
    Worwag, S.
    Bastian, R. P.
    Kittner, H. S.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2015, 29 (04) : 1069 - 1073
  • [23] Survival of radioiodine treated hyperthyroid cats that are euthyroid and hypothyroid after treatment, and effect of levothyroxine supplementation on survival time of cats with iatrogenic hypothyroidism
    Cox, Sarah E.
    Wakeling, Jennifer
    Hall, Teresa
    Williams, Tim L.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2025, 39 (01)
  • [24] Evaluation of Renal Perfusion in Hyperthyroid Cats before and after Radioiodine Treatment
    Stock, E.
    Daminet, S.
    Paepe, D.
    Buresova, E.
    Vandermeulen, E.
    Smets, P.
    Duchateau, L.
    Saunders, J. H.
    Vanderperren, K.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2017, 31 (06): : 1658 - 1663
  • [25] Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis
    Aung, Ei Thuzar
    Zammitt, Nicola N.
    Dover, Anna R.
    Strachan, Mark W. J.
    Seckl, Jonathan R.
    Gibb, Fraser W.
    CLINICAL ENDOCRINOLOGY, 2019, 90 (01) : 192 - 199
  • [26] Radioiodine treatment for pediatric hyperthyroid Grave's disease
    Ma Chao
    Xie Jiawei
    Wang Guoming
    Liu Jianbin
    Liu Wanxia
    Driedger, Al
    Zuo Shuyao
    Zhang Qin
    EUROPEAN JOURNAL OF PEDIATRICS, 2009, 168 (10) : 1165 - 1169
  • [27] The follow-up of radioiodine-treated hyperthyroid patients: Should thyroid function be monitored more frequently?
    Peacey, S. R.
    Kumar, S.
    Wright, D.
    King, R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (01) : 82 - 86
  • [28] Predictive value of scintigraphic (semi-)quantitative thyroid parameters on radioiodine therapy outcome in hyperthyroid cats
    Volckaert, Veerle
    Vandermeulen, Eva
    Duchateau, Luc
    Daminet, Sylvie
    Saunders, Jimmy H.
    Peremans, Kathelijne
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2018, 20 (04) : 370 - 377
  • [29] Serum thyroxine and thyroid-stimulating hormone concentration in hyperthyroid cats that develop azotaemia after radioiodine therapy
    Peterson, M. E.
    Nichols, R.
    Rishniw, M.
    JOURNAL OF SMALL ANIMAL PRACTICE, 2017, 58 (09) : 519 - 530
  • [30] Response to Radioiodine Therapy for Thyrotoxicosis: Disparate Outcomes for an Indigenous Population
    Tamatea, Jade A. U.
    Conaglen, John V.
    Elston, Marianne S.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2016, 2016